Categories
Pages
-

SmartMedCN

Archive for October, 2020

Ningbo: medical insurance will not reimburse drugs that are not included in the “selected drugs”-list

October 16th, 2020 | by

On June 19th, the Ningbo Municipal Medical Insurance Bureau collects opinions from the whole society for the plan of centralized procurement of medicines and medical consumable materials in public medical institutions. The “Plan” stipulates that the medical insurance fund will not pay for medicines that are similar to the selected drugs but are not included in the list of selected drugs.

 

宁波集采新规:医保不报销非中选产品

来源:医药网  2020.06.17

6月19日,浙江省宁波市医保局向全社会征集公立医疗机构药品、医用耗材集中采购的工作方案。《方案》要求,公立医疗机构若采购中选产品目录以外的同类产品,医保基金不予支付。

Implementing online medical insurance settlement of prescriptions

October 16th, 2020 | by

On May 20th, the “Opinion on Settling the Price and Medical Insurance Payment of ‘Internet+’ Medical Services” issued by the Healthcare Security Administration of Chongqing province came into effect. The “Opinion” stipulates that for the pilot program of the “Internet+” medical insurance services for common and chronic diseases, doctors can issue electronic prescriptions after online consultations and settle up the medication costs online through medical insurance, and it is allowed to deliver medicines to patients in many ways.

 

线上处方医保支付落地!处方流转迎来新机遇!

来源:医药网  2020.05.21

5月20日,重庆市医疗保障局《关于“互联网+”医疗服务价格和医保支付政策的实施意见》开始实施。《意见》提出,对于正在试点的常见病、慢性病“互联网+”医保服务,患者通过网上问诊后,可由医生开出电子处方,医保在线结算,并且允许通过多种方式为患者进行配送。

Zhejiang: restricting the medication costs

October 16th, 2020 | by

On May 11th, the Medical Insurance Bureau of Zhejiang Province issued the “Regulations of DRGs Payment on Hospitalization Expenses of Basic Medical Insurance in Zhejiang Province and Hangzhou.” The “Regulation” clarifies that designated medical institutions can retain 85% of the settlement balance of medical insurance fund while they should pay 85% of the overspending. Moreover, the “Regulation” stipulates that designated medical institutions should restrict the cost of drugs, materials, and diagnosis and treatment services that are paid by inpatients on their own, which should be within 15%  of their medical cost.

 

浙江医保新政策:医院要砍品种了  严控药费

来源:医药网  2020.05.14

5月11日,浙江省医保局印发《浙江省省级及杭州市基本医疗保险住院费用DRGs点数付费实施细则(试行)》。《细则》明确,2020年度医保基金年度结算结余部分的85%由定点医疗机构留用;超支部分的85%由定点医疗机构分担。《细则》要求,定点医疗机构应合理控制住院病人自费的药物、材料和诊疗项目费用,个人政策范围外费用比例原则上应控制在15%以内。

Hospitals and pharmacies should pay the drug cost within 30 working days

October 16th, 2020 | by

On May 12th, the NMPA issued the “Notification on Issuing the List of National Medical Security Management Services.” The “Notification” stipulates that medical institutions including hospitals and retail pharmacies should pay the drug cost for distributors and manufacturers within 30 working days.

 

国家医保局:定点医院、药店费用结算时限不超过30个工作日

来源:医药网  2020.05.13

5月12日,国家医保局发布《关于印发全国医疗保障经办政务服务事项清单的通知》。《通知》明确,定点医疗机构(含医疗机构、零售药店)费用结算办理时间应不超过30个工作日。

Improving the supervision on unreasonable or illegal behaviors of drug online trading

October 16th, 2020 | by

On April 24th, the NMPA held the video conference for renovating the unreasonable or illegal behaviors of drug online trading and administrating the circulation of medicines. The conference indicates that the drug online trading services should be further regulated to realize constant supervision over the entire trading process and ensure the medication safety; use the National Monitoring System to track and detect the unreasonable or illegal behaviors of drug online trading dynamically.

 

药品网络销售违法违规行为专项整治深入推进

来源: 医药网  2020.04.26

4月24日,国家药品监督管理局药品监管司主持召开药品网络销售违法违规行为专项整治及药品流通监管工作调度视频会。会议强调,应进一步规范药品网络销售和药品网络交易服务,实现全过程、全周期监管,强化公众用药安全保障;利用国家药品网络交易监测系统对网络药品经营违法违规行为进行动态跟踪检测。

 

 

Video conference on inspecting the implementation of “one-code-for-one-drug” on selected drugs

October 16th, 2020 | by

On April 17th, the NMPA held the video conference on inspecting the implementation of “one-code-for-one-drug” on selected drugs by centralized procurement of drugs with defined quantities. The conference stipulated that manufacturers should produce selected drugs according to the manufacturing processes that are defined by the NMPA. Besides, the Marketing Authorization Holders are encouraged to establish a mature drug  traceability system to conform to the tracing requirement of “one-code-for-one-drug.”

 

落实中选药品“一物一码”带量采集专项检查视频会召开

来源:医药网  2020.04.23

4月17日,国家药监局召开国家组织药品集中采购和使用中选药品专项检查工作调度视频会议。会议要求,企业应按照药监部门核准的生产工艺生产中选药品;督促药品上市许可人建立完善信息化追溯体系,落实中选药品“一物一码”追溯要求。